Impaired translation of CCAAT/enhancer binding protein α mRNA in bronchial smooth muscle cells of asthmatic patients

Bronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) α, which is associated with increased proliferation. We sought to assess the translational regulation of CEBPA mRNA in cultured BSM cells of healthy control subjects (n = 1...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 123; no. 3; pp. 639 - 645
Main Authors Borger, Peter, Miglino, Nicola, Baraket, Melissa, Black, Judith L., Tamm, Michael, Roth, Michael
Format Journal Article
LanguageEnglish
Published United States Mosby, Inc 01.03.2009
Subjects
Online AccessGet full text
ISSN0091-6749
1097-6825
1097-6825
DOI10.1016/j.jaci.2008.11.006

Cover

Loading…
Abstract Bronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) α, which is associated with increased proliferation. We sought to assess the translational regulation of CEBPA mRNA in cultured BSM cells of healthy control subjects (n = 11) and asthmatic patients (n = 12). Translation efficiency was studied by using a translation control reporter system driven by the control elements present in the CEBPA mRNA. Translation efficiency was determined by the ratio of 2 artificial hemagglutinin (HA.11) proteins: p23 and p12. We also analyzed levels of proteins that control translation of CEBPA mRNA, namely heterogeneous nuclear ribonucleoprotein E2, calreticulin, eukaryotic translation initiation factor (eIF4E), and 4E binding protein. Compared with healthy control subjects, BSM cells of asthmatic patients proliferate faster (2.1-fold) and are primed for IL-6 secretion. Real-time RT-PCR showed that BSM cells of asthmatic patients express normal levels of CEBPA mRNA, whereas they express lower levels of C/EBPα (p42). Transient transfections with the translation control reporter system construct showed a disturbed p12/p23 ratio in BSM cells of asthmatic patients relative to healthy control subjects, which coincided with lower levels of eIF4E. BSM cells of asthmatic patients have normal levels of CEBPA mRNA but inadequately reinitiate the translation into C/EBPα. Impaired translation control upstream of eIF4E might underlie the observed increased proliferation and priming of BSM cells of asthmatic patients.
AbstractList Bronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) alpha, which is associated with increased proliferation.BACKGROUNDBronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) alpha, which is associated with increased proliferation.We sought to assess the translational regulation of CEBPA mRNA in cultured BSM cells of healthy control subjects (n = 11) and asthmatic patients (n = 12).OBJECTIVEWe sought to assess the translational regulation of CEBPA mRNA in cultured BSM cells of healthy control subjects (n = 11) and asthmatic patients (n = 12).Translation efficiency was studied by using a translation control reporter system driven by the control elements present in the CEBPA mRNA. Translation efficiency was determined by the ratio of 2 artificial hemagglutinin (HA.11) proteins: p23 and p12. We also analyzed levels of proteins that control translation of CEBPA mRNA, namely heterogeneous nuclear ribonucleoprotein E2, calreticulin, eukaryotic translation initiation factor (eIF4E), and 4E binding protein.METHODSTranslation efficiency was studied by using a translation control reporter system driven by the control elements present in the CEBPA mRNA. Translation efficiency was determined by the ratio of 2 artificial hemagglutinin (HA.11) proteins: p23 and p12. We also analyzed levels of proteins that control translation of CEBPA mRNA, namely heterogeneous nuclear ribonucleoprotein E2, calreticulin, eukaryotic translation initiation factor (eIF4E), and 4E binding protein.Compared with healthy control subjects, BSM cells of asthmatic patients proliferate faster (2.1-fold) and are primed for IL-6 secretion. Real-time RT-PCR showed that BSM cells of asthmatic patients express normal levels of CEBPA mRNA, whereas they express lower levels of C/EBPalpha (p42). Transient transfections with the translation control reporter system construct showed a disturbed p12/p23 ratio in BSM cells of asthmatic patients relative to healthy control subjects, which coincided with lower levels of eIF4E.RESULTSCompared with healthy control subjects, BSM cells of asthmatic patients proliferate faster (2.1-fold) and are primed for IL-6 secretion. Real-time RT-PCR showed that BSM cells of asthmatic patients express normal levels of CEBPA mRNA, whereas they express lower levels of C/EBPalpha (p42). Transient transfections with the translation control reporter system construct showed a disturbed p12/p23 ratio in BSM cells of asthmatic patients relative to healthy control subjects, which coincided with lower levels of eIF4E.BSM cells of asthmatic patients have normal levels of CEBPA mRNA but inadequately reinitiate the translation into C/EBPalpha. Impaired translation control upstream of eIF4E might underlie the observed increased proliferation and priming of BSM cells of asthmatic patients.CONCLUSIONBSM cells of asthmatic patients have normal levels of CEBPA mRNA but inadequately reinitiate the translation into C/EBPalpha. Impaired translation control upstream of eIF4E might underlie the observed increased proliferation and priming of BSM cells of asthmatic patients.
Bronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) α, which is associated with increased proliferation. We sought to assess the translational regulation of CEBPA mRNA in cultured BSM cells of healthy control subjects (n = 11) and asthmatic patients (n = 12). Translation efficiency was studied by using a translation control reporter system driven by the control elements present in the CEBPA mRNA. Translation efficiency was determined by the ratio of 2 artificial hemagglutinin (HA.11) proteins: p23 and p12. We also analyzed levels of proteins that control translation of CEBPA mRNA, namely heterogeneous nuclear ribonucleoprotein E2, calreticulin, eukaryotic translation initiation factor (eIF4E), and 4E binding protein. Compared with healthy control subjects, BSM cells of asthmatic patients proliferate faster (2.1-fold) and are primed for IL-6 secretion. Real-time RT-PCR showed that BSM cells of asthmatic patients express normal levels of CEBPA mRNA, whereas they express lower levels of C/EBPα (p42). Transient transfections with the translation control reporter system construct showed a disturbed p12/p23 ratio in BSM cells of asthmatic patients relative to healthy control subjects, which coincided with lower levels of eIF4E. BSM cells of asthmatic patients have normal levels of CEBPA mRNA but inadequately reinitiate the translation into C/EBPα. Impaired translation control upstream of eIF4E might underlie the observed increased proliferation and priming of BSM cells of asthmatic patients.
Bronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) alpha, which is associated with increased proliferation. We sought to assess the translational regulation of CEBPA mRNA in cultured BSM cells of healthy control subjects (n = 11) and asthmatic patients (n = 12). Translation efficiency was studied by using a translation control reporter system driven by the control elements present in the CEBPA mRNA. Translation efficiency was determined by the ratio of 2 artificial hemagglutinin (HA.11) proteins: p23 and p12. We also analyzed levels of proteins that control translation of CEBPA mRNA, namely heterogeneous nuclear ribonucleoprotein E2, calreticulin, eukaryotic translation initiation factor (eIF4E), and 4E binding protein. Compared with healthy control subjects, BSM cells of asthmatic patients proliferate faster (2.1-fold) and are primed for IL-6 secretion. Real-time RT-PCR showed that BSM cells of asthmatic patients express normal levels of CEBPA mRNA, whereas they express lower levels of C/EBPalpha (p42). Transient transfections with the translation control reporter system construct showed a disturbed p12/p23 ratio in BSM cells of asthmatic patients relative to healthy control subjects, which coincided with lower levels of eIF4E. BSM cells of asthmatic patients have normal levels of CEBPA mRNA but inadequately reinitiate the translation into C/EBPalpha. Impaired translation control upstream of eIF4E might underlie the observed increased proliferation and priming of BSM cells of asthmatic patients.
Background Bronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) α, which is associated with increased proliferation. Objective We sought to assess the translational regulation of CEBPA mRNA in cultured BSM cells of healthy control subjects (n = 11) and asthmatic patients (n = 12). Methods Translation efficiency was studied by using a translation control reporter system driven by the control elements present in the CEBPA mRNA. Translation efficiency was determined by the ratio of 2 artificial hemagglutinin (HA.11) proteins: p23 and p12. We also analyzed levels of proteins that control translation of CEBPA mRNA, namely heterogeneous nuclear ribonucleoprotein E2, calreticulin, eukaryotic translation initiation factor (eIF4E), and 4E binding protein. Results Compared with healthy control subjects, BSM cells of asthmatic patients proliferate faster (2.1-fold) and are primed for IL-6 secretion. Real-time RT-PCR showed that BSM cells of asthmatic patients express normal levels of CEBPA mRNA, whereas they express lower levels of C/EBPα (p42). Transient transfections with the translation control reporter system construct showed a disturbed p12/p23 ratio in BSM cells of asthmatic patients relative to healthy control subjects, which coincided with lower levels of eIF4E. Conclusion BSM cells of asthmatic patients have normal levels of CEBPA mRNA but inadequately reinitiate the translation into C/EBPα. Impaired translation control upstream of eIF4E might underlie the observed increased proliferation and priming of BSM cells of asthmatic patients.
Author Baraket, Melissa
Miglino, Nicola
Tamm, Michael
Roth, Michael
Borger, Peter
Black, Judith L.
Author_xml – sequence: 1
  givenname: Peter
  surname: Borger
  fullname: Borger, Peter
  email: pieter.borger@unibas.ch
  organization: Pulmonary Cell Research, Department of Biomedicine, University Hospital Basel, Basel, Switzerland
– sequence: 2
  givenname: Nicola
  surname: Miglino
  fullname: Miglino, Nicola
  organization: Pulmonary Cell Research, Department of Biomedicine, University Hospital Basel, Basel, Switzerland
– sequence: 3
  givenname: Melissa
  surname: Baraket
  fullname: Baraket, Melissa
  organization: Pharmacology, University of Sydney, Sydney, Australia
– sequence: 4
  givenname: Judith L.
  surname: Black
  fullname: Black, Judith L.
  organization: Pharmacology, University of Sydney, Sydney, Australia
– sequence: 5
  givenname: Michael
  surname: Tamm
  fullname: Tamm, Michael
  organization: Pulmonary Cell Research, Department of Biomedicine, University Hospital Basel, Basel, Switzerland
– sequence: 6
  givenname: Michael
  surname: Roth
  fullname: Roth, Michael
  organization: Pulmonary Cell Research, Department of Biomedicine, University Hospital Basel, Basel, Switzerland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19121862$$D View this record in MEDLINE/PubMed
BookMark eNqFUl1rFDEUDdJit9U_4IPkybeZJpmdSSIiLIsfhVJB63PIZO64GWeSNckI_Vn-EX-TGbdSKNi-5APOOffec-4pOnLeAUIvKCkpoc35UA7a2JIRIkpKS0KaJ2hFieRFI1h9hFaESFo0fC1P0GmMA8n_Ssin6IRKyqho2ArNF9Ne2wAdTkG7OOpkvcO-x9vtZnN9Dm6nnYGAW-s6677hffAJrMO_f-Hp89UG52cbvDM7q0ccJ-_TDk9zNCNgA-MYFykd027Kwgbv8wkuxWfouNdjhOe39xn6-v7d9fZjcfnpw8V2c1mYmqxTUbVd1Yu-50RzybmuWy2FaKkEwbU0kE3oOmGYpLziuoI1k0K2ci3zmFUr-uoMvTro5rZ_zBCTmmxc-tIO_BxVwwljVS0z8OUtcG4n6NQ-2EmHG_XPqAxgB4AJPsYA_R2EqCUNNaglDbWkoShVOY1MEvdIxqa_Dmez7fgw9c2BCtmenxaCiiZbZ6DLYZmkOm8fpr-9Rzejddbo8TvcQBz8HFw2XlEVmSLqy7Ipy6IQQfK8pM4Cr_8v8Fj1P4hvzog
CitedBy_id crossref_primary_10_18632_oncotarget_7209
crossref_primary_10_1016_j_pupt_2012_05_006
crossref_primary_10_1159_000353427
crossref_primary_10_1371_journal_pone_0081494
crossref_primary_10_1155_2013_875403
crossref_primary_10_1186_s12890_019_0911_x
crossref_primary_10_1111_j_1476_5381_2009_00188_x
crossref_primary_10_1183_09031936_00174310
crossref_primary_10_1152_ajplung_90624_2008
crossref_primary_10_1183_09031936_00019810
crossref_primary_10_1016_j_imbio_2019_05_006
crossref_primary_10_1074_jbc_M112_373274
crossref_primary_10_1111_j_1365_2222_2009_03270_x
crossref_primary_10_1016_j_pupt_2012_08_005
crossref_primary_10_1155_2012_783290
crossref_primary_10_1530_JOE_11_0369
crossref_primary_10_1183_09031936_00013111
crossref_primary_10_34133_2022_9891689
crossref_primary_10_1172_jci_insight_152762
crossref_primary_10_1183_09031936_00068010
crossref_primary_10_1155_2018_9363820
crossref_primary_10_1165_rcmb_2011_0293OC
crossref_primary_10_1016_j_pharmthera_2011_02_001
crossref_primary_10_1016_j_cellsig_2016_07_004
crossref_primary_10_1016_S0954_6111_12_70005_7
Cites_doi 10.1084/jem.20070956
10.1038/ng791
10.1128/MCB.22.20.7242-7257.2002
10.1074/jbc.273.44.28545
10.1161/01.CIR.99.17.2276
10.1067/mai.2002.130047
10.1073/pnas.90.17.8219
10.1038/nprot.2006.274
10.1073/pnas.90.20.9606
10.1101/gad.14.15.1920
10.1152/ajplung.00389.2001
10.1164/rccm.200205-416OC
10.1074/jbc.M411134200
10.1016/j.jaci.2005.03.046
10.1093/nar/gnj029
10.1086/315027
10.1097/01.TP.0000101822.50960.AB
10.1002/jcp.20605
10.1164/rccm.200501-082PP
10.1016/S1471-4914(02)02424-3
10.1164/ajrccm.164.3.2010109
10.1056/NEJMoa021660
10.1042/BST0340012
10.1016/j.jaci.2006.07.056
10.1056/NEJMoa064707
10.1016/S1569-9048(03)00142-3
10.1165/rcmb.2003-0272OC
10.1038/nrc1363
ContentType Journal Article
Copyright 2009 American Academy of Allergy, Asthma & Immunology
American Academy of Allergy, Asthma & Immunology
Copyright_xml – notice: 2009 American Academy of Allergy, Asthma & Immunology
– notice: American Academy of Allergy, Asthma & Immunology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jaci.2008.11.006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6825
EndPage 645
ExternalDocumentID 19121862
10_1016_j_jaci_2008_11_006
S0091674908021805
1_s2_0_S0091674908021805
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
AACTN
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c504t-3bd3f8ff70a7977a5ba988b19e87a9ce016dd8c291737a3e42989b9499383b8f3
IEDL.DBID .~1
ISSN 0091-6749
1097-6825
IngestDate Fri Jul 11 09:45:40 EDT 2025
Thu Apr 03 07:04:39 EDT 2025
Tue Jul 01 04:31:45 EDT 2025
Thu Apr 24 23:03:34 EDT 2025
Sun Apr 06 06:54:18 EDT 2025
Wed Apr 02 07:43:51 EDT 2025
Tue Aug 26 17:58:56 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords C/EBPα
C/EBP
eIF4E
LP
4EBP
bronchial smooth muscle cell hyperplasia
Asthma
messenger RNA translation
PDGF
TCRS
mTOR
uORF
HA
BSM
SP
hnRNPE2
Platelet-derived growth factor
Heterogeneous nuclear ribonucleoprotein E2
Hemagglutinin
Translation control reporter system
Long peptide
Bronchial smooth muscle
Eukaryotic translation initiation factor 4E
Short peptide
CCAAT/enhancer binding protein
4E binding protein
Mammalian target of rapamycin
Upstream open reading frame
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c504t-3bd3f8ff70a7977a5ba988b19e87a9ce016dd8c291737a3e42989b9499383b8f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://www.jacionline.org/article/S0091674908021805/pdf
PMID 19121862
PQID 67022359
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_67022359
pubmed_primary_19121862
crossref_primary_10_1016_j_jaci_2008_11_006
crossref_citationtrail_10_1016_j_jaci_2008_11_006
elsevier_sciencedirect_doi_10_1016_j_jaci_2008_11_006
elsevier_clinicalkeyesjournals_1_s2_0_S0091674908021805
elsevier_clinicalkey_doi_10_1016_j_jaci_2008_11_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-03-01
PublicationDateYYYYMMDD 2009-03-01
PublicationDate_xml – month: 03
  year: 2009
  text: 2009-03-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 2009
Publisher Mosby, Inc
Publisher_xml – name: Mosby, Inc
References Trian, Benard, Bequeret, Rossignol, Girodot, Ghosh (bib6) 2007; 204
Timchenko, Iakova, Welm, Cai, Timchenko (bib27) 2002; 22
Stephens, Li, Jiang, Unruh, Ma (bib2) 2003; 137
Johnson, Roth, Tamm, Hughes, Ge, King (bib5) 2001; 164
Wiesenthal, Leutz, Calkhoven (bib10) 2006; 34
Eickelberg, Roth, Mussmann, Rüdiger, Tamm, Perruchoud (bib15) 1999; 99
Borger, Matsumoto, Boustany, Gencay, Tamm, Burgess (bib9) 2007; 119
WHO/NHLBI Workshop Report (bib1) 1995
Mathews, Sonenberg, Hershey (bib25) 2000
Azolla, Havryk, Chhajed, Hostettler, Black, Johnson (bib28) 2004; 77
Nerlov (bib20) 2004; 4
Miglino, Tamm, Roth, Borger (bib31) 2007; 30
Lin, MacDougald, Diehl, Lane (bib21) 1993; 90
Lekstrom-Himes, Xanthopoulos (bib17) 1998; 273
Calkhoven, Müller, Leutz (bib22) 2002; 8
Grunstein, Veler, Shan, Larson, Grunsetin, Chuang (bib30) 2005; 116
Zhong, Gencay, Bubendorf, Burgess, Parson, Robinson (bib12) 2006; 207
Borger, Black, Roth (bib18) 2002; 110
Chen, Zhao, Rao, Inoue, Hao (bib16) 2005; 280
Halayko, Kartha, Stelmack, McConville, Tam, Camoretti-Mercado (bib29) 2004; 31
Burgess, Johnson, Ge, Au, Poniris, McParland (bib8) 2003; 167
Ossipow, Descombes, Schibler (bib23) 1993; 90
Borger, Black, Tamm, Roth (bib4) 2006; 174
Ma, Cheng, Kong, Wang, Unruh, Stephens (bib7) 2002; 283
Hamilton, Stoneley, Spriggs, Bushell (bib24) 2006; 34
Cox, Thomson, Rubin, Niven, Corris, Siersted (bib3) 2007; 356
Calkhoven, Müller, Leutz (bib19) 2000; 14
Borger, Koëter, Timmerman, Vellenga, Tomee, Kauffman (bib14) 1999; 180
Roth, Johnson, Borger, Bihl, Rüdiger, King (bib13) 2004; 351
Perrotti, Cesi, Trotta, Guerzoni, Santilli, Campbell (bib26) 2002; 30
Wiesenthal, Leutz, Calkhoven (bib11) 2006; 1
Burgess (10.1016/j.jaci.2008.11.006_bib8) 2003; 167
Grunstein (10.1016/j.jaci.2008.11.006_bib30) 2005; 116
Timchenko (10.1016/j.jaci.2008.11.006_bib27) 2002; 22
Perrotti (10.1016/j.jaci.2008.11.006_bib26) 2002; 30
Borger (10.1016/j.jaci.2008.11.006_bib9) 2007; 119
Calkhoven (10.1016/j.jaci.2008.11.006_bib22) 2002; 8
Azolla (10.1016/j.jaci.2008.11.006_bib28) 2004; 77
Lekstrom-Himes (10.1016/j.jaci.2008.11.006_bib17) 1998; 273
Ossipow (10.1016/j.jaci.2008.11.006_bib23) 1993; 90
Hamilton (10.1016/j.jaci.2008.11.006_bib24) 2006; 34
Wiesenthal (10.1016/j.jaci.2008.11.006_bib11) 2006; 1
Eickelberg (10.1016/j.jaci.2008.11.006_bib15) 1999; 99
Lin (10.1016/j.jaci.2008.11.006_bib21) 1993; 90
Wiesenthal (10.1016/j.jaci.2008.11.006_bib10) 2006; 34
Borger (10.1016/j.jaci.2008.11.006_bib18) 2002; 110
Zhong (10.1016/j.jaci.2008.11.006_bib12) 2006; 207
Borger (10.1016/j.jaci.2008.11.006_bib14) 1999; 180
Nerlov (10.1016/j.jaci.2008.11.006_bib20) 2004; 4
Roth (10.1016/j.jaci.2008.11.006_bib13) 2004; 351
Borger (10.1016/j.jaci.2008.11.006_bib4) 2006; 174
Miglino (10.1016/j.jaci.2008.11.006_bib31) 2007; 30
Trian (10.1016/j.jaci.2008.11.006_bib6) 2007; 204
Chen (10.1016/j.jaci.2008.11.006_bib16) 2005; 280
Calkhoven (10.1016/j.jaci.2008.11.006_bib19) 2000; 14
Mathews (10.1016/j.jaci.2008.11.006_bib25) 2000
Halayko (10.1016/j.jaci.2008.11.006_bib29) 2004; 31
Ma (10.1016/j.jaci.2008.11.006_bib7) 2002; 283
Stephens (10.1016/j.jaci.2008.11.006_bib2) 2003; 137
WHO/NHLBI Workshop Report (10.1016/j.jaci.2008.11.006_bib1) 1995
Johnson (10.1016/j.jaci.2008.11.006_bib5) 2001; 164
Cox (10.1016/j.jaci.2008.11.006_bib3) 2007; 356
References_xml – volume: 90
  start-page: 8219
  year: 1993
  end-page: 8223
  ident: bib23
  article-title: CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials
  publication-title: Proc Natl Acad Sci U S A
– volume: 273
  start-page: 28545
  year: 1998
  end-page: 28548
  ident: bib17
  article-title: Biological role of the CCAAT/enhancer-binding protein family of transcription factors
  publication-title: J Biol Chem
– volume: 356
  start-page: 1327
  year: 2007
  end-page: 1337
  ident: bib3
  article-title: Asthma control during the year after bronchial thermoplasty
  publication-title: N Engl J Med
– volume: 110
  start-page: 841
  year: 2002
  end-page: 846
  ident: bib18
  article-title: Asthma and the CCAAT-enhancer binding proteins: a holistic view on airway inflammation and remodeling
  publication-title: J Allergy Clin Immunol
– volume: 119
  start-page: 98
  year: 2007
  end-page: 105
  ident: bib9
  article-title: Disease specific expression and regulation of CCAAT/enhancer binding proteins in asthma and COPD
  publication-title: J Allergy Clin Immunol
– volume: 22
  start-page: 7242
  year: 2002
  end-page: 7257
  ident: bib27
  article-title: Calreticulin interacts with C/EBPα and C/EBPβ mRNAs and represses translation of C/EBP proteins
  publication-title: Mol Cell Biol
– volume: 34
  start-page: e23
  year: 2006
  ident: bib10
  article-title: A translation control reporter system (TCRS) for the analysis of translationally controlled processes in the vertebrate cell
  publication-title: Nucleic Acids Res
– volume: 283
  start-page: L1181
  year: 2002
  end-page: L1189
  ident: bib7
  article-title: Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects
  publication-title: Am J Physiol Lung Cell Mol Physiol
– volume: 30
  start-page: e1667
  year: 2007
  ident: bib31
  article-title: House dust mite allergens may induce ASM remodeling/hyperplasia by reducing C/EBPα levels
  publication-title: Eur Respir J
– volume: 1
  start-page: 1531
  year: 2006
  end-page: 1537
  ident: bib11
  article-title: Analysis of translation initiation using a translation control reporter system
  publication-title: Nat Protocol
– year: 1995
  ident: bib1
  article-title: Global strategy for asthma management and prevention
– volume: 180
  start-page: 1267
  year: 1999
  end-page: 1274
  ident: bib14
  article-title: Proteases from
  publication-title: J Infect Dis
– volume: 4
  start-page: 394
  year: 2004
  end-page: 400
  ident: bib20
  article-title: C/EBPα mutations in acute myeloid leukemias
  publication-title: Nat Rev Cancer
– volume: 31
  start-page: 266
  year: 2004
  end-page: 275
  ident: bib29
  article-title: Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation
  publication-title: Am J Respir Cell Mol Biol
– volume: 30
  start-page: 48
  year: 2002
  end-page: 58
  ident: bib26
  article-title: BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2
  publication-title: Nat Genet
– volume: 137
  start-page: 125
  year: 2003
  end-page: 140
  ident: bib2
  article-title: The biophysics of asthmatic airway smooth muscle
  publication-title: Respir Physiol Neurobiol
– volume: 351
  start-page: 560
  year: 2004
  end-page: 574
  ident: bib13
  article-title: Dysfunctional interaction of C/EBPα and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells
  publication-title: N Engl J Med
– volume: 99
  start-page: 2276
  year: 1999
  end-page: 2282
  ident: bib15
  article-title: Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells
  publication-title: Circulation
– volume: 207
  start-page: 540
  year: 2006
  end-page: 552
  ident: bib12
  article-title: ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells
  publication-title: J Cell Physiol
– volume: 204
  start-page: 3173
  year: 2007
  end-page: 3181
  ident: bib6
  article-title: Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma
  publication-title: J Exp Med
– year: 2000
  ident: bib25
  article-title: Origins and principles of translation control. Translational control of gene expression
– volume: 8
  start-page: 577
  year: 2002
  end-page: 583
  ident: bib22
  article-title: Translational control of gene expression and disease
  publication-title: Trends Mol Med
– volume: 116
  start-page: 94
  year: 2005
  end-page: 101
  ident: bib30
  article-title: Proasthmatic effects and mechanisms of action of the dust mite allergen, Der p 1, in airway smooth muscle
  publication-title: J Allergy Clin Immunol
– volume: 167
  start-page: 71
  year: 2003
  end-page: 77
  ident: bib8
  article-title: Expression of connective tissue growth factor in asthmatic airway smooth muscle cells
  publication-title: Am J Respir Crit Care Med
– volume: 77
  start-page: 275
  year: 2004
  end-page: 280
  ident: bib28
  article-title: Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation
  publication-title: Transplantation
– volume: 34
  start-page: 12
  year: 2006
  end-page: 16
  ident: bib24
  article-title: TOPs and their regulation
  publication-title: Biochem Soc
– volume: 174
  start-page: 367
  year: 2006
  end-page: 372
  ident: bib4
  article-title: Asthma—is it due to an abnormal airway smooth muscle cell?
  publication-title: Am J Respir Crit Care Med
– volume: 280
  start-page: 16354
  year: 2005
  end-page: 16359
  ident: bib16
  article-title: C/EBPβ and its binding element are required for NFκB-induced COX2 expression following hypertonic stress
  publication-title: J Biol Chem
– volume: 90
  start-page: 9606
  year: 1993
  end-page: 9610
  ident: bib21
  article-title: A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity
  publication-title: Proc Natl Acad Sci U S A
– volume: 164
  start-page: 474
  year: 2001
  end-page: 477
  ident: bib5
  article-title: Airway smooth muscle cell proliferation is increased in asthma
  publication-title: Am J Respir Crit Care Med
– volume: 14
  start-page: 1920
  year: 2000
  end-page: 1932
  ident: bib19
  article-title: Translational control of C/EBPα and C/EBPβ isoform expression
  publication-title: Genes Dev
– volume: 204
  start-page: 3173
  year: 2007
  ident: 10.1016/j.jaci.2008.11.006_bib6
  article-title: Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma
  publication-title: J Exp Med
  doi: 10.1084/jem.20070956
– volume: 30
  start-page: 48
  year: 2002
  ident: 10.1016/j.jaci.2008.11.006_bib26
  article-title: BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2
  publication-title: Nat Genet
  doi: 10.1038/ng791
– volume: 22
  start-page: 7242
  year: 2002
  ident: 10.1016/j.jaci.2008.11.006_bib27
  article-title: Calreticulin interacts with C/EBPα and C/EBPβ mRNAs and represses translation of C/EBP proteins
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.22.20.7242-7257.2002
– volume: 273
  start-page: 28545
  year: 1998
  ident: 10.1016/j.jaci.2008.11.006_bib17
  article-title: Biological role of the CCAAT/enhancer-binding protein family of transcription factors
  publication-title: J Biol Chem
  doi: 10.1074/jbc.273.44.28545
– volume: 99
  start-page: 2276
  year: 1999
  ident: 10.1016/j.jaci.2008.11.006_bib15
  article-title: Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells
  publication-title: Circulation
  doi: 10.1161/01.CIR.99.17.2276
– volume: 110
  start-page: 841
  year: 2002
  ident: 10.1016/j.jaci.2008.11.006_bib18
  article-title: Asthma and the CCAAT-enhancer binding proteins: a holistic view on airway inflammation and remodeling
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2002.130047
– volume: 90
  start-page: 8219
  year: 1993
  ident: 10.1016/j.jaci.2008.11.006_bib23
  article-title: CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.90.17.8219
– volume: 1
  start-page: 1531
  year: 2006
  ident: 10.1016/j.jaci.2008.11.006_bib11
  article-title: Analysis of translation initiation using a translation control reporter system
  publication-title: Nat Protocol
  doi: 10.1038/nprot.2006.274
– volume: 90
  start-page: 9606
  year: 1993
  ident: 10.1016/j.jaci.2008.11.006_bib21
  article-title: A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.90.20.9606
– volume: 14
  start-page: 1920
  year: 2000
  ident: 10.1016/j.jaci.2008.11.006_bib19
  article-title: Translational control of C/EBPα and C/EBPβ isoform expression
  publication-title: Genes Dev
  doi: 10.1101/gad.14.15.1920
– volume: 283
  start-page: L1181
  year: 2002
  ident: 10.1016/j.jaci.2008.11.006_bib7
  article-title: Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00389.2001
– volume: 167
  start-page: 71
  year: 2003
  ident: 10.1016/j.jaci.2008.11.006_bib8
  article-title: Expression of connective tissue growth factor in asthmatic airway smooth muscle cells
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200205-416OC
– volume: 280
  start-page: 16354
  year: 2005
  ident: 10.1016/j.jaci.2008.11.006_bib16
  article-title: C/EBPβ and its binding element are required for NFκB-induced COX2 expression following hypertonic stress
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M411134200
– year: 1995
  ident: 10.1016/j.jaci.2008.11.006_bib1
– volume: 116
  start-page: 94
  year: 2005
  ident: 10.1016/j.jaci.2008.11.006_bib30
  article-title: Proasthmatic effects and mechanisms of action of the dust mite allergen, Der p 1, in airway smooth muscle
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2005.03.046
– volume: 34
  start-page: e23
  year: 2006
  ident: 10.1016/j.jaci.2008.11.006_bib10
  article-title: A translation control reporter system (TCRS) for the analysis of translationally controlled processes in the vertebrate cell
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gnj029
– volume: 180
  start-page: 1267
  year: 1999
  ident: 10.1016/j.jaci.2008.11.006_bib14
  article-title: Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms
  publication-title: J Infect Dis
  doi: 10.1086/315027
– volume: 77
  start-page: 275
  year: 2004
  ident: 10.1016/j.jaci.2008.11.006_bib28
  article-title: Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation
  publication-title: Transplantation
  doi: 10.1097/01.TP.0000101822.50960.AB
– volume: 207
  start-page: 540
  year: 2006
  ident: 10.1016/j.jaci.2008.11.006_bib12
  article-title: ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.20605
– volume: 174
  start-page: 367
  year: 2006
  ident: 10.1016/j.jaci.2008.11.006_bib4
  article-title: Asthma—is it due to an abnormal airway smooth muscle cell?
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200501-082PP
– volume: 8
  start-page: 577
  year: 2002
  ident: 10.1016/j.jaci.2008.11.006_bib22
  article-title: Translational control of gene expression and disease
  publication-title: Trends Mol Med
  doi: 10.1016/S1471-4914(02)02424-3
– volume: 164
  start-page: 474
  year: 2001
  ident: 10.1016/j.jaci.2008.11.006_bib5
  article-title: Airway smooth muscle cell proliferation is increased in asthma
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.164.3.2010109
– volume: 351
  start-page: 560
  year: 2004
  ident: 10.1016/j.jaci.2008.11.006_bib13
  article-title: Dysfunctional interaction of C/EBPα and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa021660
– volume: 34
  start-page: 12
  year: 2006
  ident: 10.1016/j.jaci.2008.11.006_bib24
  article-title: TOPs and their regulation
  publication-title: Biochem Soc
  doi: 10.1042/BST0340012
– volume: 30
  start-page: e1667
  issue: suppl 51
  year: 2007
  ident: 10.1016/j.jaci.2008.11.006_bib31
  article-title: House dust mite allergens may induce ASM remodeling/hyperplasia by reducing C/EBPα levels
  publication-title: Eur Respir J
– volume: 119
  start-page: 98
  year: 2007
  ident: 10.1016/j.jaci.2008.11.006_bib9
  article-title: Disease specific expression and regulation of CCAAT/enhancer binding proteins in asthma and COPD
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2006.07.056
– volume: 356
  start-page: 1327
  year: 2007
  ident: 10.1016/j.jaci.2008.11.006_bib3
  article-title: Asthma control during the year after bronchial thermoplasty
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa064707
– volume: 137
  start-page: 125
  year: 2003
  ident: 10.1016/j.jaci.2008.11.006_bib2
  article-title: The biophysics of asthmatic airway smooth muscle
  publication-title: Respir Physiol Neurobiol
  doi: 10.1016/S1569-9048(03)00142-3
– volume: 31
  start-page: 266
  year: 2004
  ident: 10.1016/j.jaci.2008.11.006_bib29
  article-title: Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regulates contractile protein accumulation in airway myocyte differentiation
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2003-0272OC
– year: 2000
  ident: 10.1016/j.jaci.2008.11.006_bib25
– volume: 4
  start-page: 394
  year: 2004
  ident: 10.1016/j.jaci.2008.11.006_bib20
  article-title: C/EBPα mutations in acute myeloid leukemias
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1363
SSID ssj0009389
Score 2.067691
Snippet Bronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) α, which is associated with...
Background Bronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) α, which is...
Bronchial smooth muscle (BSM) cells of asthmatic patients have an impaired expression of CCAAT/enhancer binding protein (C/EBP) alpha, which is associated with...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 639
SubjectTerms Allergy and Immunology
Asthma
Asthma - genetics
Asthma - immunology
Asthma - metabolism
Bronchi - immunology
Bronchi - metabolism
bronchial smooth muscle cell hyperplasia
C/EBPα
Calreticulin - immunology
Calreticulin - metabolism
CCAAT-Enhancer-Binding Protein-alpha - biosynthesis
CCAAT-Enhancer-Binding Protein-alpha - immunology
Cell Proliferation
Cells, Cultured
Eukaryotic Initiation Factor-4E - immunology
Eukaryotic Initiation Factor-4E - metabolism
Heterogeneous-Nuclear Ribonucleoproteins - immunology
Heterogeneous-Nuclear Ribonucleoproteins - metabolism
Humans
Interleukin-6 - biosynthesis
Interleukin-6 - immunology
messenger RNA translation
Myocytes, Smooth Muscle - immunology
Myocytes, Smooth Muscle - metabolism
Protein Biosynthesis
RNA, Messenger - immunology
RNA, Messenger - metabolism
Title Impaired translation of CCAAT/enhancer binding protein α mRNA in bronchial smooth muscle cells of asthmatic patients
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0091674908021805
https://www.clinicalkey.es/playcontent/1-s2.0-S0091674908021805
https://dx.doi.org/10.1016/j.jaci.2008.11.006
https://www.ncbi.nlm.nih.gov/pubmed/19121862
https://www.proquest.com/docview/67022359
Volume 123
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwELYQSFUvVenvUkp96K1KN1nH2D5GK9DSij1UIHGzYscRQWyC1tlr34kX4Zk6EzugqpRKvUWRHcee8cw4-eYbQj5zAWG4sTZJq0omucpUopizCbSuBee1MhIThU-Xh4vz_NsFv9gi8zEXBmGV0fYHmz5Y63hnGldzetM0mOOrEEKvMFs0kwOPKbLXgU5__fkA81BMhhBYZQm2jokzAeN1Vdom4CmRyROrHj3unP4WfA5O6PgleRGjR1qEF9wlW659RZ6dxv_jr8nmBHY3TKiiPfqggHOjXU3n86I4m7r2EoW8pqYZklnowNLQtPTulq5-LAsKl2bdtYh_vqZ-1YEY6WrjYSyKX_g9Pqr0_eXA80ojJ6t_Q86Pj87miyQWVkgsT_M-YaZitaxrkZYC4r-Sm1JJaTLlpCiVdbA4IDk7g6McEyVzOdK0G6SxgfOskTV7S7bbrnXvCa0EV84gCV8u88pinqu1ua1k6owsczYh2bii2kbWcSx-ca1HeNmVRimEcphwGAEpTMiX-z43gXPjydZsFJQes0nB_mlwCU_2Eo_1cj5uYa8z7Wc61X-o2YTw-56_aeo_R_w0apGGLYxSK1vXbbw-FBBIMa4m5F1QrodZqwxrhs32_nPMD-R5-PuFmLl9st2vN-4jBFG9ORh2yQHZKU6-L5a_ANVvG1M
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEBZhA20vJf3fpm106K2YtVdyLB3N0rDbZPdQNpCbkGSZOGTtsPY-WF4kz9QZS04oTVPozRiPZWl-Zc18Q8jXNIMw3FgbxUUhIi4TGUnmbARPl1maltIILBRero7n5_zHRXqxR2ZDLQymVQbb7216b63DnUlYzclNVWGNr8QUeonVoolAHNN9RKfiI7KfL07nqwfsXSZ8FCyTCAlC7YxP87rStvIplQjmiY2PHvdPf4s_ez90ckBehgCS5v4bX5E9V78mz5bhiPwN2S1AwWFOBe3QDflUN9qUdDbL8_XE1ZfI5y01VV_PQnughqqmd7d083OVU7g026bGFOhr2m4a4CTd7FoYi-JP_hZfpdvusod6pQGWtX1Lzk--r2fzKPRWiGwa8y5ipmClKMss1hmEgDo1WgphEulEpqV1sDjAPDuF3RzLNHMckdoNItnAltaIkr0jo7qp3QdCiyyVziAOHxe8sFjqai23hYidEZqzMUmGFVU2AI9j_4trNWSYXSnkgu-ICfsR4MKYfLunufGwG08-zQZGqaGgFEygAq_wJFX2GJVrgxa3KlHtVMXqD0kbk_Se8jdh_eeIR4MUKdBi5JquXbNr1XEGsRRL5Zi898L1MGuZYNuw6cf_HPOIPJ-vl2fqbLE6PSQv_GEYptB9IqNuu3OfIabqzJegM78Ae2weBA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impaired+translation+of+CCAAT%2Fenhancer+binding+protein+alpha+mRNA+in+bronchial+smooth+muscle+cells+of+asthmatic+patients&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Borger%2C+Peter&rft.au=Miglino%2C+Nicola&rft.au=Baraket%2C+Melissa&rft.au=Black%2C+Judith+L&rft.date=2009-03-01&rft.issn=1097-6825&rft.eissn=1097-6825&rft.volume=123&rft.issue=3&rft.spage=639&rft_id=info:doi/10.1016%2Fj.jaci.2008.11.006&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674909X00035%2Fcov150h.gif